HAE
Haemonetics Corporation
$108.80
+0.54%
2026-08-21
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.
Key Fundamentals
P/E Ratio
43.86
Forward P/E
15.82
EPS (TTM)
$2.07
ROE
11.2%
Revenue Growth (YoY)
5.6%
Profit Margin
7.1%
Debt/Equity
140.26
Price/Book
4.93
Beta
0.52
Market Cap
$4.13B
Avg Volume (10D)
889K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$109.57
60D Low
$64.79
Avg Volume
792K
Latest Close
$108.80
Get breakout alerts for HAE
Sign up for Breakout Scanner to receive daily notifications when HAE triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Haemonetics Corporation (HAE) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors HAE daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. HAE operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.